Search research articles
Contact Us
Filters
Showing results (231-240 of 263) with videos related to
Page
of 27
Sort By:
Medicine and Science in Sports and Exercise
|
November 18, 2025
Associations of Accelerometer-Determined Sedentary and Physical Activity Behaviors with Heart Failure Biomarkers During Midlife: CARDIA Study
Kelley Pettee Gabriel, Bjoern Hornikel, Erin E Dooley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 2, 2024
Lipid and Glucose Profiles in Pregnant Women With HIV on Tenofovir-based Antiretroviral Therapy
Ahizechukwu C Eke, Sean S Brummel, Muktar H Aliyu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 15, 2022
Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial
Mandar S Paradkar, Bella Devaleenal D, Tisungane Mvalo, et al.
Biorxiv : the Preprint Server for Biology
|
February 9, 2026
Bidirectional fibrogenic cross-talk revealed in a human iPSC-derived epithelial-mesenchymal co-culture model of pulmonary fibrosis
Andrea B Alber, George Kwong, Vishal K Gupta, et al.
Open Forum Infectious Diseases
|
April 22, 2021
Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India
Vidya Mave, Sanjay Gaikwad, Madhusudan Barthwal, et al.
Journal of Physical Activity & Health
|
December 6, 2025
Results From the 2024 United States Report Card on Physical Activity for Children and Youth
Jordan A Carlson, Mallory Moon, Chelsea Steel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2024
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis
Huy X Ngo, Ava Y Xu, Gustavo E Velásquez, et al.
Emerging Infectious Diseases
|
March 2, 2025
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
Ekaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 30, 2022
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)
April C Pettit, Patrick P J Phillips, Ekaterina Kurbatova, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 16, 2024
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial
Ava Y Xu, Gustavo E Velásquez, Nan Zhang, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 263) with videos related to
Sort By:
Page
of 27
Medicine and Science in Sports and Exercise
|
November 18, 2025
Associations of Accelerometer-Determined Sedentary and Physical Activity Behaviors with Heart Failure Biomarkers During Midlife: CARDIA Study
Kelley Pettee Gabriel, Bjoern Hornikel, Erin E Dooley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 2, 2024
Lipid and Glucose Profiles in Pregnant Women With HIV on Tenofovir-based Antiretroviral Therapy
Ahizechukwu C Eke, Sean S Brummel, Muktar H Aliyu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 15, 2022
Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial
Mandar S Paradkar, Bella Devaleenal D, Tisungane Mvalo, et al.
Biorxiv : the Preprint Server for Biology
|
February 9, 2026
Bidirectional fibrogenic cross-talk revealed in a human iPSC-derived epithelial-mesenchymal co-culture model of pulmonary fibrosis
Andrea B Alber, George Kwong, Vishal K Gupta, et al.
Open Forum Infectious Diseases
|
April 22, 2021
Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India
Vidya Mave, Sanjay Gaikwad, Madhusudan Barthwal, et al.
Journal of Physical Activity & Health
|
December 6, 2025
Results From the 2024 United States Report Card on Physical Activity for Children and Youth
Jordan A Carlson, Mallory Moon, Chelsea Steel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2024
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis
Huy X Ngo, Ava Y Xu, Gustavo E Velásquez, et al.
Emerging Infectious Diseases
|
March 2, 2025
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
Ekaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 30, 2022
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)
April C Pettit, Patrick P J Phillips, Ekaterina Kurbatova, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 16, 2024
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial
Ava Y Xu, Gustavo E Velásquez, Nan Zhang, et al.
Page
of 27